>중동 및 아프리카 자동화 세포 배양 시장, 제품별(소모품, 기기), 유형별(무한 세포주 배양, 유한 세포주 배양), 응용 분야별(약물 개발, 줄기 세포 연구, 재생 의학, 암 연구, 백신, 기타), 최종 사용자별(생명공학 회사, 연구 기관, 학술 연구 기관, 기타) 산업 동향 및 2029년까지의 예측.
중동 및 아프리카 자동 세포 배양 시장 분석 및 통찰력
자동화된 세포 배양 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
중동 및 아프리카 자동화 세포 배양 시장은 2022년에서 2029년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년에서 2029년의 예측 기간 동안 5.6%의 CAGR로 성장하고 있으며 2029년까지 2억 7,093만 유로에 도달할 것으로 예상한다고 분석합니다. 백신 생산에서 세포 배양 기술에 대한 수요 증가 와 다양한 응용 분야에서 세포 배양 기술의 광범위한 수용이 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다.
보고서 메트릭 |
세부 |
예측 기간 |
2022년부터 2029년까지 |
기준 연도 |
2021 |
역사적 연도 |
2020 (2019-2014까지 사용자 정의 가능) |
양적 단위 |
매출(백만 유로), 볼륨(단위), 가격(유로) |
다루는 세그먼트 |
제품별(소모품, 기구), 유형별(무한 세포주 배양, 유한 세포주 배양), 응용 분야별(약물 개발, 줄기세포 연구, 재생 의학 , 암 연구, 백신 , 기타), 최종 사용자별(생명공학 기업, 연구 기관, 학술 연구 기관, 기타). |
적용 국가 |
남아프리카 공화국, 중동 및 아프리카의 나머지 지역 |
시장 참여자 포함 |
Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG 및 기타 |
중동 및 아프리카 자동 세포 배양 시장 정의
Automated cell culture systems are instruments that mechanically carries out the steps involved in growing and maintaining a cell culture. Useful in any lab that works with cell biology, cell signaling, protein expression, or drug discovery, an automated cell culture system helps to grow cell cultures while saving labor time and reducing errors. Automated cell culture systems can be capable of diluting samples, growing cultures in liquid with constant swirling, plating cultures, or placing cultures in wells. Increase in demand for 3D cell cultures, increasing collaboration among market players, and increasing outsourcing facilities are expected to provide a lucrative growth opportunity for the market. However, high cost of automated cell culture systems, and limitations associated with automated cell cultures are the factors expected to restraint the market growth in the forecast period.
Middle East and Africa Automated Cell Cultures Market Dynamics
This section deals with understanding the market drivers, opportunity, restraint, and challenge. All of this is discussed in detail below:
- Drivers
Increasing Demand for Cell Culture Technology in Vaccine Production
Cell culture is an essential tool for molecular and cellular biology research. Today, most biotechnology products primarily rely on mass culturing cell lines. Cell cultures have applications in diverse areas and serve as a model system for numerous research efforts.
An increase in funding from the government for cell-based research is significantly triggering the market's growth. In addition, cell culture techniques are widely being used as an alternative to current egg-based strategies for developing cell-based vaccines. Cell culture has potential applications in developing viral vaccines with increased communicable diseases and pandemic risk. Thus, cell culture technology is being extensively used in developing U.S. licensed vaccines such as vaccines against rubella, smallpox, chickenpox, hepatitis, rotavirus, and polio.
Technological Advancements in Cell Culture Technology Systems
As the demand for advanced cell culture technologies in vaccine production, cancer research, and virology, among others, is increasing, certain technological developments are taking place in automated cell culture.
Thus, market players operating in the market adopt various technological developments in cell culture equipment to boost their business in various dimensions and lead to market growth. This factor could drive the Middle East and Africa automated cell cultures market growth.
- Restraint
High Cost of Automated Cell Culture Systems
The cost of the product is the major setback for the market as it is expected to decrease the demand due to high cost. In the case of automated cell culture systems, the price is also high, and below the given instance will showcase the product's price.
The instruments and consumables-related products such as cell counters, reagents, buffers, and others have high prices, which shows that the cost of automated cell cultures is the primary factor expected to restrain the Middle East and Africa automated cell cultures market in the forecasted period.
- Opportunity
New Product Launches and Technology Developments
Pharmaceutical and biotechnology-driven companies are working towards developing and launching new products and technologies for automated cell culture advancement and making the treatment and diagnosis methods more reachable. This has also increased the demand for an automated cell culture market for 3D cell cultures. The development of new bioreactors, platforms, softwares has led to an advancement in the automated cell culture market and its growth.
The new products and technologies launched and worked upon create good opportunities for the Middle East and Africa automated cell cultures market. The new platforms with advanced technologies act as a footstep closer to the advancement of the market.
- Challenge
Development and Maintenance of Expertise
Recruitment and retention of trained and qualified staff, staff development, capital budgets for equipment purchase, operating budget management, facility infrastructure, and change management all require proper attention for the growth and success of any market. Failure to meet needs in any of these areas can lead to a serious weakness that, if uncorrected, may compromise the credibility of a laboratory and create a situation that will be difficult to correct in the short term.
Testing and maintaining the level of expertise in testing laboratories is a tough task, and it needs high experience, which sometimes is not accessible, which causes the development process for a particular company to hinder. Thus it is anticipated to challenge the Middle East and Africa automated cell cultures market growth in the forecasted period.
Recent Developments
- In July 2021, BD launched bdbiosciences.com, an updated digital marketplace for flow cytometry. The new website provides an enhanced online purchasing experience for flow cytometry users and their procurement teams
- In January 2021, Hamilton Company joined its high-throughput automated workflow ingenuity with Artel’s performance testing expertise so that users may be assured of robust and continuous automated liquid handling workstation performance integrity. Artel and Hamilton will co-develop standard automated scripts for Hamilton’s automated workstations as part of the collaboration
Middle East and Africa Automated Cell Cultures Market Scope
Middle East and Africa automated cell cultures market is segmented into Product, Type, Application, and End User. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
중동 및 아프리카 자동 세포 배양 시장, 제품별
- 소모품
- 악기
제품을 기준으로 중동 및 아프리카 자동 세포 배양 시장은 소모품과 장비로 구분됩니다.
중동 및 아프리카 자동 세포 배양 시장, 유형별
- 무한 세포주 배양
- 유한 세포주 배양
유형을 기준으로 중동 및 아프리카 자동 세포 배양 시장은 무한 세포주 배양 및 유한 세포주 배양으로 구분됩니다.
중동 및 아프리카 자동화 세포 배양 시장, 응용 분야별
- 약물 개발
- 줄기세포 연구
- 재생의학
- 암 연구
- 백신
- 기타
중동 및 아프리카 자동 세포 배양 시장은 응용 분야를 기준으로 약물 개발, 줄기세포 연구, 재생 의학, 암 연구, 백신 및 기타로 구분됩니다.
중동 및 아프리카 자동 세포 배양 시장, 최종 사용자별
- 바이오텍 회사
- 연구 기관
- 학술 연구 기관
- 다른
중동 및 아프리카 자동 세포 배양 시장은 최종 사용자를 기준으로 생명공학 기업, 연구 기관, 학술 연구 기관 등으로 구분됩니다.
중동 및 아프리카 자동 세포 배양 시장 지역 분석/통찰력
중동 및 아프리카 자동 세포 배양 시장을 분석하고, 제품, 유형, 응용 분야 및 최종 사용자별로 시장 규모 정보를 제공합니다.
이 시장 보고서에서 다루는 국가는 남아프리카공화국, 중동 및 아프리카입니다.
- 2022년에는 중동 및 아프리카 자동 세포 배양 시장이 줄기세포 연구, 백신 생산, 재생 의약품 생산 및 약물 발견에 대한 응용 분야가 증가함에 따라 성장할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 중동 및 아프리카 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 중동 및 아프리카 자동 세포 배양 시장 점유율 분석
중동 및 아프리카 자동화 세포 배양 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 중동 및 아프리카 자동화 세포 배양 시장에 대한 회사의 초점과만 관련이 있습니다.
중동 및 아프리카 자동 세포 배양 시장의 주요 시장 주체는 Lonza, Merck KGaA, Thermo Fisher Scientific Inc., BD, Eppendorf AG, Advanced Instruments, Benchmark scientific, Inc., BioSpherix, Ltd., Biotron Healthcare, Bulldog Bio, Cell Culture Company, LLC, CellGenix GmbH, ChemoMetec, Corning Incorporated, Cytiva(Danahar Corporation의 자회사), FUJIFILM Holdings America Corporation, Hemilton Company, Hitachi, Ltd., Kawasaki Heavy Industries, ltd., HiMedia Laboratories, NanoEntek America, Inc., Nexcelom Bioscience LLC., PromoCell GmbH, RWD Life Science Co., LTD, Sartorius AG, Scientica Instrumentation, Inc., SHIBUYA CORPORATION, Sphere Fluidics Limited, Tecan Trading AG, Thrive Bioscience, Inc. 및 기타입니다.
연구 방법론: 중동 및 아프리카 자동 세포 배양 시장
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 중동 및 아프리카 대 지역, 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORK FOR MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING DEMAND FOR CELL CULTURE TECHNOLOGY IN VACCINE PRODUCTION
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN CELL CULTURE TECHNOLOGY SYSTEMS
6.1.3 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS
6.1.4 GROWING BIOTECHNOLOGY SECTOR, ALONG WITH RISING HEALTHCARE EXPENDITURE
6.1.5 ADVANTAGES OF AUTOMATED CELL CULTURE SYSTEMS OVER MANUAL METHODS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AUTOMATED CELL CULTURE SYSTEMS
6.2.2 LIMITATIONS ASSOCIATED WITH AUTOMATED CELL CULTURES
6.2.3 MAINTENANCE AND UPDATING OF EQUIPMENT
6.2.4 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.3 OPPORTUNITIES
6.3.1 NEW PRODUCT LAUNCHES AND TECHNOLOGY DEVELOPMENTS
6.3.2 INCREASING COLLABORATION AMONG MARKET PLAYERS
6.3.3 INCREASING OUTSOURCING FACILITIES
6.3.4 INCREASE IN DEMAND FOR 3D CELL CULTURE
6.4 CHALLENGES
6.4.1 DEVELOPMENT AND MAINTENANCE OF EXPERTISE
6.4.2 LACK OF INFRASTRUCTURE FOR CELL-BASED RESEARCH IN EMERGING ECONOMIES
7 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 MEDIA
7.2.1.1 SERUM FREE MEDIA
7.2.1.2 CLASSICAL MEDIA & SALTS
7.2.1.3 STEM CELL CULTURE MEDIA
7.2.1.4 SPECIALTY MEDIA
7.2.2 BUFFERS AND SUPPLEMENTS
7.2.2.1 PLASMA
7.2.2.2 SERA
7.2.2.3 FETAL BOVINE SERA
7.2.2.4 ADULT BOVINE SERA
7.2.2.5 OTHERS ANIMAL SERA
7.2.3 REAGENTS
7.2.3.1 SUPPLEMENTS & GROWTH FACTORS
7.2.3.2 BUFFERS & CHEMICALS
7.2.3.3 CELL DISASSOCIATION REAGENTS
7.2.3.4 BALANCED SALT SOLUTIONS
7.2.3.5 ATTACHMENT & MATRIX FACTORS
7.2.3.6 ANTIBIOTICS/ANTIMYCOTICS
7.2.3.7 CONTAMINATION DETECTION KITS
7.2.3.8 CRYOPROTECTIVE REAGENTS
7.2.3.9 OTHERS CELL CULTURE REAGENTS
7.2.4 ACCESSORIES
7.3 INSTRUMENTS
7.3.1 SUPPORTING EQUIPMENTS
7.3.1.1 CELL COUNTERS
7.3.1.2 IMAGE BASED CELL COUNTERS
7.3.1.3 FLOW CYTOMETERS
7.3.1.4 COULTER COUNTERS
7.3.1.5 CELL EXPANSION
7.3.1.6 LIQUID HANDLERS
7.3.1.7 OTHERS
7.3.2 BIOREACTORS
7.3.2.1 SINGLE USE BIOREACTORS
7.3.2.2 CONVENTIONAL BIOREACTORS
7.3.2.3 OTHERS
7.3.3 STORAGE EQUIPMENTS
7.3.3.1 REFRIGERATORS & FREEZERS
7.3.3.2 CRYOSTORAGE SYSTEMS
7.3.3.3 OTHERS
8 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE
8.1 OVERVIEW
8.2 INFINITE CELL LINE CULTURES
8.3 FINITE CELL LINE CULTURES
9 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DEVELOPMENT
9.3 STEM CELL RESEARCH
9.3.1 EMBRYONIC STEM CELLS
9.3.2 TISSUE-SPECIFIC STEM CELLS
9.3.3 MESENCHYMAL STEM CELLS
9.3.4 INDUCED PLURIPOTENT STEM CELLS
9.4 REGENERATIVE MEDICINE
9.4.1 STEM CELL THERAPY
9.4.2 PLATELET-RICH PLASMA THERAPY (OR PRP INJECTIONS)
9.4.3 TISSUE ENGINEERING
9.4.4 AMNIOTIC-MEMBRANE DERIVED STEM CELLS
9.5 CANCER RESEARCH
9.6 VACCINES
9.7 OTHERS
10 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER
10.1 OVERVIEW
10.2 BIOTECH COMPANIES
10.3 RESEARCH ORGANIZATIONS
10.4 ACADEMIC RESEARCH INSTITUTES
10.5 OTHERS
11 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY REGION
11.1 MIDDLE EAST & AFRICA
11.1.1 SOUTH AFRICA
11.1.2 REST OF MIDDLE EAST AND AFRICA
12 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
13 COMPANY PROFILE
13.1 LONZA
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 COMPANY SHARE ANALYSIS
13.1.4 PRODUCT PORTFOLIO
13.1.5 RECENT DEVELOPMENTS
13.1.6 SWOT ANALYSIS
13.2 MERCK KGAA
13.2.1 COMPANY SNAPSHOT
13.2.2 RECENT FINANCIALS
13.2.3 COMPANY SHARE ANALYSIS
13.2.4 PRODUCT PORTFOLIO
13.2.5 RECENT DEVELOPMENTS
13.2.6 SWOT ANALYSIS
13.3 THERMO FISHER SCIENTIFIC INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 RECENT FINANCIALS
13.3.3 COMPANY SHARE ANALYSIS
13.3.4 PRODUCT PORTFOLIO
13.3.5 RECENT DEVELOPMENTS
13.3.6 SWOT ANALYSIS
13.4 BD
13.4.1 COMPANY SNAPSHOT
13.4.2 RECENT FINANCIALS
13.4.3 COMPANY SHARE ANALYSIS
13.4.4 PRODUCT PORTFOLIO
13.4.5 RECENT DEVELOPMENTS
13.4.6 SWOT ANALYSIS
13.5 EPPENDORF AG
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 COMPANY SHARE ANALYSIS
13.5.4 PRODUCT PORTFOLIO
13.5.5 RECENT DEVELOPMENTS
13.5.6 SWOT ANALYSIS
13.6 ADVANCED INSTRUMENTS
13.6.1 COMPANY SNAPSHOT
13.6.2 PRODUCT PORTFOLIO
13.6.3 RECENT DEVELOPMENTS
13.7 BENCHMARK SCIENTIFIC INC.
13.7.1 COMPANY SNAPSHOT
13.7.2 PRODUCT PORTFOLIO
13.7.3 RECENT DEVELOPMENTS
13.8 BIOSPHERIX LTD.
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 BIOTRON HEALTHCARE
13.9.1 COMPANY SNAPSHOT
13.9.2 PRODUCT PORTFOLIO
13.9.3 RECENT DEVELOPMENTS
13.1 BULLDOG-BIO, INC.
13.10.1 COMPANY SNAPSHOT
13.10.2 PRODUCT PORTFOLIO
13.11 CELL CULTURE COMPANY, LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 PRODUCT PORTFOLIO
13.11.3 RECENT DEVELOPMENT
13.12 CELLGENIX GMBH
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 CHEMOMETEC
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENT
13.14 CORNING INCORPORATED
13.14.1 COMPANY SNAPSHOT
13.14.2 RECENT FINANCIALS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 CYTIVA (SUBSIDIARY OF DANAHER CORPORATION)
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 FUJIFILM HOLDINGS AMERICA CORPORATION
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 HAMILTON COMPANY
13.17.1 COMPANY SNAPSHOT
13.17.2 PRODUCT PORTFOLIO
13.17.3 RECENT DEVELOPMENTS
13.18 HITACHI, LTD.
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT DEVELOPMENTS
13.19 KAWASAKI HEAVY INDUSTRIES, LTD.
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT DEVELOPMENTS
13.2 HIMEDIA LABORATORIES
13.20.1 COMPANY SNAPSHOT
13.20.2 PRODUCT PORTFOLIO
13.20.3 RECENT DEVELOPMENTS
13.21 NANOENTEK AMERICA INC. (A SUBSIDIARY OF NANOENTEK)
13.21.1 COMPANY SNAPSHOT
13.21.2 PRODUCT PORTFOLIO
13.21.3 RECENT DEVELOPMENTS
13.22 NEXCELOM BIOSCIENCE LLC.
13.22.1 COMPANY SNAPSHOT
13.22.2 PRODUCT PORTFOLIO
13.22.3 RECENT DEVELOPMENTS
13.23 PROMOCELL GMBH
13.23.1 COMPANY SNAPSHOT
13.23.2 PRODUCT PORTFOLIO
13.23.3 RECENT DEVELOPMENTS
13.24 RWD LIFE SCIENCE CO LTD.
13.24.1 COMPANY SNAPSHOT
13.24.2 PRODUCT PORTFOLIO
13.24.3 RECENT DEVELOPMENTS
13.25 SARTORIUS AG
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT DEVELOPMENTS
13.26 SCIENTICA INSTRUMENTATION, INC.
13.26.1 COMPANY SNAPSHOT
13.26.2 PRODUCT PORTFOLIO
13.26.3 RECENT DEVELOPMENTS
13.27 SHIBUYA CORPORATION
13.27.1 COMPANY SNAPSHOT
13.27.2 RECENT FINANCIALS
13.27.3 PRODUCT PORTFOLIO
13.27.4 RECENT DEVELOPMENTS
13.28 SPHERE FLUIDICS LIMITED
13.28.1 COMPANY SNAPSHOT
13.28.2 PRODUCT PORTFOLIO
13.28.3 RECENT DEVELOPMENTS
13.29 TECAN TRADING AG
13.29.1 COMPANY SNAPSHOT
13.29.2 RECENT FINANCIALS
13.29.3 PRODUCT PORTFOLIO
13.29.4 RECENT DEVELOPMENT
13.3 THRIVE BIOSCIENCE, INC.
13.30.1 COMPANY SNAPSHOT
13.30.2 PRODUCT PORTFOLIO
13.30.3 RECENT DEVELOPMENTS
14 QUESTIONNAIRE
15 RELATED REPORTS
표 목록
TABLE 1 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 2 MIDDLE EAST & AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 4 MIDDLE EAST & AFRICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 5 MIDDLE EAST & AFRICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 6 MIDDLE EAST & AFRICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCTS, 2020-2029 (EURO MILLION)
TABLE 7 MIDDLE EAST & AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 8 MIDDLE EAST & AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 9 MIDDLE EAST & AFRICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 10 MIDDLE EAST & AFRICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 11 MIDDLE EAST & AFRICA STORAGE EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 12 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 13 MIDDLE EAST & AFRICA INFINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 14 MIDDLE EAST & AFRICA FINITE CELL LINE CULTURES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 15 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 16 MIDDLE EAST & AFRICA DRUG DEVELOPMENT IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 17 MIDDLE EAST & AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 18 MIDDLE EAST & AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 19 MIDDLE EAST & AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 20 MIDDLE EAST & AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 21 MIDDLE EAST & AFRICA CANCER RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 22 MIDDLE EAST & AFRICA VACCINES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 23 MIDDLE EAST & AFRICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 24 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 25 MIDDLE EAST & AFRICA BIOTECH COMPANIES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 26 MIDDLE EAST & AFRICA RESEARCH ORGANIZATIONS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 27 MIDDLE EAST & AFRICA ACADEMIC RESEARCH INSTITUTES IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 28 MIDDLE EAST & AFRICA OTHERS IN AUTOMATED CELL CULTURES MARKET, BY REGION, 2020-2029 (EURO MILLION)
TABLE 29 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY COUNTRY, 2020-2029 (EURO MILLION)
TABLE 30 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 31 MIDDLE EAST AND AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 32 MIDDLE EAST AND AFRICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 33 MIDDLE EAST AND AFRICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 34 MIDDLE EAST AND AFRICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 35 MIDDLE EAST AND AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 36 MIDDLE EAST AND AFRICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 37 MIDDLE EAST AND AFRICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 38 MIDDLE EAST AND AFRICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 39 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 40 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 41 MIDDLE EAST AND AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 42 MIDDLE EAST AND AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 43 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 44 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 45 SOUTH AFRICA CONSUMABLES IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 46 SOUTH AFRICA MEDIA IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 47 SOUTH AFRICA BUFFERS & SUPPLEMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 48 SOUTH AFRICA REAGENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 49 SOUTH AFRICA INSTRUMENTS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 50 SOUTH AFRICA SUPPORTING EQUIPMENTS IN AUTOMATED CELL CULTURES MARKET BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 51 SOUTH AFRICA BIOREACTORS IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 52 SOUTH AFRICA STORAGE EQUIPMENT IN AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
TABLE 53 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY TYPE, 2020-2029 (EURO MILLION)
TABLE 54 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 55 SOUTH AFRICA STEM CELL RESEARCH IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 56 SOUTH AFRICA REGENERATIVE MEDICINE IN AUTOMATED CELL CULTURES MARKET, BY APPLICATION, 2020-2029 (EURO MILLION)
TABLE 57 SOUTH AFRICA AUTOMATED CELL CULTURES MARKET, BY END USER, 2020-2029 (EURO MILLION)
TABLE 58 REST OF MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET, BY PRODUCT, 2020-2029 (EURO MILLION)
그림 목록
FIGURE 1 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: SEGMENTATION
FIGURE 11 WIDE ACCEPTANCE OF CELL CULTURE TECHNIQUES IN VARIOUS APPLICATIONS AND THE GROWING BIOTECHNOLOGY SECTOR ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET IN THE FORECAST PERIOD
FIGURE 12 CONSUMABLES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET
FIGURE 14 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2021
FIGURE 15 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, 2022-2029 (EURO MILLION)
FIGURE 16 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2021
FIGURE 19 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, 2022-2029 (EURO MILLION)
FIGURE 20 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 21 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2021
FIGURE 23 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, 2022-2029 (EURO MILLION)
FIGURE 24 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 25 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2021
FIGURE 27 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, 2022-2029 (EURO MILLION)
FIGURE 28 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET : SNAPSHOT (2021)
FIGURE 31 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021)
FIGURE 32 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 MIDDLE EAST AND AFRICA AUTOMATED CELL CULTURES MARKET : BY PRODUCT (2022-2029)
FIGURE 35 MIDDLE EAST & AFRICA AUTOMATED CELL CULTURES MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.